Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial-Reference-Cited by-同舟云学术

Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial

Published:2008-10 Issue:2 Volume:143 Page:191-200
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Pönisch Wolfram,Rozanski Marta,Goldschmidt Hartmut,Hoffmann Franz Albert,Boldt Thomas,Schwarzer Andreas,Ritter Ute,Rohrberg Robert,Schwalbe Elke,Uhlig Jens,Zehrfeld Thomas,Schirmer Veronika,Haas Antje,Kreibich Ute,Niederwieser Dietger,

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2008.07076.x/fullpdf

Reference52 articles.

1. The treatment of multiple myeloma;Alexanian;New England Journal of Medicine,1994

2. Thalidomide and dexamethasone for resistant multiple myeloma;Anagnostopoulos;British Journal of Haematology,2003

3. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome;Attal;New England Journal of Medicine,1996

4. Bendamustine;Balfour;Drugs,2001

5. Treatment approaches for relapsing and refractory multiple myeloma;Blade;Acta Oncologica,2000

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting the role of alkylating agents in multiple myeloma: Up-to-date evidence and future perspectives;Critical Reviews in Oncology/Hematology;2023-07

2. Impact of the changing landscape of induction therapy prior to autologous stem cell transplantation in 540 newly diagnosed myeloma patients: a retrospective real-world study;Journal of Cancer Research and Clinical Oncology;2022-08-20

3. What’s Old is New: The Past, Present and Future Role of Thalidomide in the Modern-Day Management of Multiple Myeloma;Targeted Oncology;2022-06-30

4. Bendamustine in combination with pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: A phase II trial;British Journal of Haematology;2022-05-02

5. Bendamustine-Based Regimens as Salvage Therapy in Refractory/Relapsed Multiple Myeloma Patients: A Retrospective Real-Life Analysis by the Polish Myeloma Group;Journal of Clinical Medicine;2021-11-24